MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/2397198320941322

Медицинская библиотека · Journal of scleroderma and related disorders · 2020

Mast Cell Activation in the Systemic Sclerosis Esophagus.

Tom Kevin, Mehta Bhaven K, Hoffmann Aileen, Aren Kathleen, Carns Mary, Lee Jungwha, Martyanov Viktor, Popovich Dillon, Kosarek Noelle, Wood Tammara, Brenner Darren, Carlson Dustin A, Ostilla Lorena, Willcocks Emma, Bryce Paul, Wechsler Joshua B, Whitfield Michael L, Hinchcliff Monique

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Previously, we discovered similar esophageal gene expression patterns in patients with systemic sclerosis (SSc) and eosinophilic esophagitis (EoE) where eosinophil/mast cell-targeted therapies are beneficial. Because SSc and EoE patients experience similar esophageal symptoms, we hypothesized that eosinophil/mast cell-directed therapy may potentially benefit SSc patients. Herein, we determine the association between esophageal mast cell quantities, gene expression and clinical parameters in order to identify SSc patients who may benefit from eosinophil/mast cell-directed therapy.

METHODS

Esophageal biopsies from SSc patients and healthy participants were stained for tryptase, a mast cell marker, and associations with relevant clinical parameters including 24h esophageal pH testing were assessed. Intra-epithelial mast cell density was quantified by semi-automated microscopy. Microarray data were utilized for functional and gene set enrichment analyses and to identify intrinsic subset (IS) assignment, an SSc molecular classification system that includes inflammatory, proliferative, limited and normal-like subsets.

RESULTS

Esophageal biopsies from 40 SSc patients (39 receiving proton pump inhibition) and eleven healthy participants were studied. Mast cell numbers in both the upper esophagus (rs = 0.638, p = 0.004) and the entire (upper + lower) esophagus (rs = 0.562, p = 0.019) significantly correlated with acid exposure time percentage. The inflammatory, fibroproliferative, and normal-like ISs originally defined in skin biopsies were identified in esophageal biopsies. Although esophageal mast cell numbers in SSc patients and healthy participants were similar, gene expression for mast cell-related pathways showed significant upregulation in the inflammatory IS of SSc patients compared to patients classified as proliferative or normal-like.

DISCUSSION: Esophageal mast cell numbers are heterogeneous in SSc patients and may correlate with acid exposure. Patients with inflammatory IS profiles in the esophagus demonstrate more tryptase staining. Mast cell targeted therapy may be a useful therapeutic approach in SSc patients belonging to the inflammatory IS, but additional studies are warranted.

Для цитирования: Tom Kevin, Mehta Bhaven K, Hoffmann Aileen, Aren Kathleen, Carns Mary, Lee Jungwha, Martyanov Viktor, Popovich Dillon, Kosarek Noelle, Wood Tammara, Brenner Darren, Carlson Dustin A, Ostilla Lorena, Willcocks Emma, Bryce Paul, Wechsler Joshua B, Whitfield Michael L, Hinchcliff Monique. Mast Cell Activation in the Systemic Sclerosis Esophagus.. Journal of scleroderma and related disorders. 2020. DOI: 10.1177/2397198320941322.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.